BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 28, 2022
View Archived Issues
ON-203, a second-generation anti-oxMIF antibody with improved efficacy
Read More
RAC1 variants found to cause a novel developmental syndrome
Read More
LETM1 causes mitochondrial osmotic dysregulation tied to pathology
Read More
MagicMed Industries discloses new 5-HT2A receptor agonists
Read More
Suzhou Vincentage Pharma patents GLP-1 receptor agonists
Read More
Targeting of CD46 allows PET imaging of mesothelioma with [89Zr]DFO-YS5
Read More
Chengdu Easton Biopharmaceuticals discloses BET inhibitors
Read More
Chinese researchers identify new JAK1 inhibitors
Read More
IMPACT Therapeutics synthesizes new NUAK inhibitors
Read More
RBM22 inversely correlates with prostate cancer aggressiveness
Read More
EAN 2022: At several scales, connective landscape provides lens for neurology
Read More
New pH-responsive albumin-binding ligands show targeted tumor uptake in vivo
Read More
Use of [89Zr]Prot-FH for neutrophil imaging during fungal infection
Read More
Ainos reports preclinical data on low-dose oral interferon-alpha Veldona against COVID-19
Read More
Hillstream partners with Sapien to study synergy between HSB-1216 and immune checkpoint inhibitors
Read More
NCI grant supports Penn's development of intraoperative imaging technology for NSCLC
Read More
Kuria licenses rights to SCOHIA's SCO-116 for ocular and dermatologic diseases
Read More
Astellas and Sutro partner to discover and develop novel immunostimulatory antibody-drug conjugates
Read More
Ideaya selects Pol Theta Helicase development candidate
Read More
Confo awarded grant to support GPCR drug discovery
Read More
